Sensus Healthcare shares surge 17.57% after-hours as H.C. Wainwright raises price target to $12 and Lake Street initiates at $18 with 'buy' ratings.

Tuesday, Jan 13, 2026 4:14 pm ET1min read
SRTS--
Sensus Healthcare (NASDAQ:SRTS) surged 17.57% in after-hours trading following H.C. Wainwright’s upgrade of its price target from $11 to $12 and reaffirmation of a "buy" rating on February 11, 2025. The move followed a series of bullish analyst actions, including a $18 price target from Lake Street Capital in late January and a "buy" rating from Maxim Group in November 2024, alongside strong Q3 2024 financial results showing a 127% revenue increase. The recent analyst optimism, combined with positive coverage highlighting strategic growth initiatives and partnerships, likely drove the sharp after-hours rally, reflecting renewed confidence in the company’s revenue potential and market position.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet